Pediatric emergency medicine trisk 1197

initial assessment, 1297
management, 1297 –1299
triage consideration, 1297
Inverse psoriasis, 468 , 470 f
Ionizing radiation, 700
I-PASS (Illness severity, Patient summary, Action list, Situational
awareness and contingency plan, Synthesis by receiver), 5 , 5 t, 14
Ipratropium, 185
Ipsilateral esotropia, 175
Ipsilateral hypertropia, 175 , 181
Ipsilateral limb ataxia, 107
Ipsilateral preauricular adenopathy, 312
Iridocyclitis, 1016 –1017
Iritis, 172 –173 , 184 , 188
Iron-deficiency anemia, 417
Iron poisoning, 1046 –1048 , 1047 f
Irregular heart rate, 373 , 424
Irregular pupils, 186
Irritable bowel syndrome, distension in, 87
Irritant contact dermatitis, 435
Irritative pharyngitis, 508
Irritative vulvovaginitis, 530
Isoniazid, 558 , 1052 –1053
Isopropyl alcohol, 1054 –1055
Isotonic dehydration, 149
Isotonic fluid, 699
Isovaleric acidemia, 335
Isradipine, 246
IV access, 30 , 30 t
IV levetiracetam (Keppra), 497
Ixodes scapularis , 1363

J
Jacksonian spread, 491
Jaundice, 358
breast milk, 295 , 298
in cases of serious infection, 295 –296


cholestatic, 289 , 292
clinical examination of, 296
conjugated hyperbilirubinemia and, 289 –293
unconjugated hyperbilirubinemia and, 294 –300
Jaw fractures
avulses, 1110
evidences, 1109
Hanks balanced salt solution, 1109 , 1110 f
mandibular fractures/dislocations
clinical assessment, 1109
clinical recognition, 1109
management, 1109 –1110
maxillary fractures, 1110
reduction of dislocated mandible, 1111 f
temporomandibular joint, dislocation of, 1111 f
treatment goals, 1109
Jefferson fracture, 1239 –1241
anteroposterior (AP), 1240 f
lateral cervical spine radiograph, 1241 f
Jervell and Lange-Nielsen syndrome (JLNS), 222
Jimson weed, 185
Jogger’s nipple, 112

Joint line tenderness, 277
Joint pain
common causes, 403 t
diagnostic approach to, 404 f
differential diagnosis, 402 , 403 t
evaluation and decision, 402 –407
laboratory studies, 403
fever and, 406 t
life-threatening causes, 403 t
viral etiology, 1362
Jugular venous distension (JVD), 482
Jumper’s knee, 279
Juvenile amyotrophic lateral sclerosis (ALS), 557
Juvenile breast hypertrophy, 113
Juvenile dermatomyositis (JDM), 1000 , 1006 –1010 , 1007 t, 1008 f


clinical assessment, 1006 –1008
clinical course of, 1006
clinical recognition, 1006
EULAR/ACR classification criteria, 1007 t
evidences, 1006
general management, 1008 –1009
management of complications and emergencies, 1009 t
calcinosis, 1010
cardiac complications, 1010
GI complications, 1010
respiratory complications, 1009 –1010
Juvenile fibroadenoma, 113
Juvenile idiopathic arthritis (JIA), 184 , 188 , 203 , 302 , 306 , 406 , 1011

–1018 , 1012 f–1013 f, 1362
classification systems for, 1011 t
clinical considerations, 1011 –1013
evidences, 1011
general management, 1013 –1014
laboratory and radiologic features, 1013
management of complications and emergencies
cardiac complications, 1016
cervical spine involvement, 1017
cricoarytenoid arthritis, 1018
fever, 1016
flare of a single joint, 1017
iridocyclitis, 1016 –1017
pulmonary complications, 1016
ruptured popliteal cyst, 1017
medications for, 1014 –1015 , 1014 t
drug toxicity and, 1015
neck stiffness and, 329
subgroups, 1012 t
Juvenile myasthenia gravis, 559
Juvenile nasopharyngeal angiofibromas, 166
Juvenile osteochondritis dissecans (JOCD), 1369
Juvenile plantar dermatosis, 435
Juvenile polyps, 1305 –1306 , 1306 f


Juvenile rheumatoid arthritis (JRA), 406
Juvenile spring eruption, 436
Juvenile systemic sclerosis (JSSc), 1000
classification criteria for, 1000 t

complications, 1001 t
Juvenile Tillaux fracture, 259 , 261 f
Juvenile xanthogranuloma (JXG), 1354
JXG. See Juvenile xanthogranulomas (JXG)

K
Kaolin-pectin, 156
Kaposi varicelliform eruption (KVE), 474 –475 , 474 f, 474 t
Karo corn syrup, 131
Kasabach–Merritt phenomenon, 464
Kasai hepatoportoenterostomy (HPE), 292
Katz extractor, 1113
Kawasaki disease (KD), 171 , 203 , 224 , 293 , 311 , 317 , 322 , 351 , 351
f, 352 , 366 –367 , 369 , 402 , 406 , 413 , 415 , 440 , 454 , 502 , 510 –511 ,
522 , 528 , 544 , 615 , 1021 f, 1349
aspirin therapy, 1025
cardiac abnormalities in, 1025 –1026
clinical assessment, 1022 –1024
clinical assessment of incomplete, 1024
clinical findings, 1024 t
coronary aneurysms in, 1026
corticosteroids for, 1025
diagnostic criteria, 1020 t
differential diagnosis, 1022 t
echocardiographic criteria, 1024 t
evaluation of suspected, 1023 f
evidences, 1019 –1020
goals of treatment, 1020
IVIG therapy, 1025
management of complications and emergencies, 1025 –1027

myocardial infarction in, 1026
pathology of, 1020 t
refractory, 1026 –1027